Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/2000
06/21/2000EP1009430A1 Vaccines
06/21/2000EP1009429A1 Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
06/21/2000EP1009428A1 Vaginal suppository vaccine for urogenital infections
06/21/2000EP1009420A1 Conjugates useful in the treatment of prostate cancer
06/21/2000EP1009413A2 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
06/21/2000EP1009410A1 Method for producing stable acetylsalicylic acid solutions
06/21/2000EP1009396A1 Pharmaceutical formulation comprising a 2-aminoacetamide derivative and an ion exchange resin
06/21/2000EP1009390A1 Prolonged anesthesia in joints and body spaces
06/21/2000EP1009387A1 Stabilized sustained release tramadol formulations
06/21/2000EP1009384A1 A method of administering liposomal encapsulated taxane
06/21/2000EP1009381A1 Carotenoid microemulsions
06/21/2000EP0825875B1 Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence
06/21/2000EP0820304B1 Chlamydia vaccines
06/21/2000DE19916224C1 Synthetic molecule for delivering active ingredient to cell, used e.g. to treat human immune deficiency virus infection, comprises the ingredient linked to VP2 or 3 peptide from polyoma virus
06/21/2000DE19856443A1 Stabilisiertes Antithrombin III-Präparat Stabilized antithrombin III preparation
06/21/2000CN1257431A Chemically and thermally stable norastemizole formulations
06/21/2000CN1257425A Gastroretentive controlled release microspheres for improved drug delivery
06/21/2000CN1257423A Preparation of powder agglomerates
06/21/2000CN1257421A Medicinal aerosol products
06/21/2000CN1053581C Yunnan Baiyao (white drug-powder) tablet and preparation method thereof
06/21/2000CN1053570C Pharmaceutical composition of piperidinoalkanol-decongestant combination preparation process
06/21/2000CN1053569C Injectable solution and process for preparing same
06/20/2000US6077939 Methods and kits for making polypeptides having a single covalently bound N-terminal water-soluble polymer
06/20/2000US6077871 Droloxifene pharmaceutical compositions
06/20/2000US6077867 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
06/20/2000US6077843 Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
06/20/2000US6077835 Administering composition comprising compacted, unaggregated nucleic acid complexes, each complex consisting essentially of a single nucleic molecule encoding a protein and one or more carrier molecules to facilitate their uptake by target cells
06/20/2000US6077834 Combining non-viral receptor ligand and cationic lipid ; adding polynucleotide to form molecular mixture; introducing molecular mixture to cell to enhance delivery of polynucleotide to cell
06/20/2000US6077829 Comprising brain derived neurotrophic factor(bdnf), polyoxyethylene sorbitan monooleate as nonionic surfactant, and carrier; prevents denaturing and polymerization of bdnf; storage stability
06/20/2000US6077714 Method for the preparation of free radical pharmaceuticals diagnostics and devices using selenium conjugates
06/20/2000US6077663 Composition for introducing nucleic acid complexes into higher eucaryotic cells
06/20/2000US6077545 Photosensitive composition, acid generator and organosilicon compound
06/20/2000US6077543 Atomizing solutions to produce drops; lung drug delivery
06/20/2000US6077541 Enteric coating; capsules
06/20/2000US6077539 Rapid bioavailability of metoclopramide; long acting non-steroidal antiinflammatory agent; free of ht3 receptor antagonists; side effect reduction
06/20/2000US6077535 Sorbitol carrier
06/20/2000US6077532 Pharmaceutical ion exchange resin composition
06/20/2000US6077531 Capsule with micronized progesterone suspension in oil and estradiol in microspheres; menopause
06/20/2000US6077529 Applying lipid transfer protein in aqueous solution to surface of lung and oronasal passage
06/20/2000US6077528 Percutaneous preparation
06/20/2000US6077523 Process to manufacture implants containing bioactive peptides
06/20/2000US6077499 First conjugate of a tumor targeting moiety, a therapeutic agent, and first member of a binding pair; clearing agent; and second conjugate of the complementary binding member of the binding pair, and second therapeutic agent
06/20/2000US6077232 Anticoagulant composition
06/20/2000CA2169091C Silicone grafted thermoplastic elastomeric copolymers and hair and skin care compositions containing the same
06/20/2000CA2164619C Once-a-day metoprolol oral dosage form
06/20/2000CA2144845C Germicidal detergent-iodine compositions having reduced detergent content
06/20/2000CA2011262C Use of mixed micelles
06/20/2000CA2000479C Vasopermeability-enhancing conjugates
06/15/2000WO2000034451A1 Treatment of pompe's disease
06/15/2000WO2000034444A2 Method and composition for preserving viruses
06/15/2000WO2000034296A2 Conjugates comprising galactose alpha 1,3 galactosyl epitopes and methods of using same
06/15/2000WO2000034293A1 Method for preparation of disodium pamidronate
06/15/2000WO2000034246A1 Crystalline form of an octahydro-benzo(f)quinolin-3-one derivative
06/15/2000WO2000034245A2 Crystalline form of benzoquinoline-3-one derivatve as inhibitor of 5-alpha reductase
06/15/2000WO2000033893A1 Sterile complex of therapeutic peptide bond to a polysaccharide
06/15/2000WO2000033892A1 A medicinal aerosol formulation
06/15/2000WO2000033888A2 Prodrug compounds and process for preparation thereof
06/15/2000WO2000033887A2 Methods and formulations for reducing circulating antibodies
06/15/2000WO2000033886A1 Dry powder complexes for gene delivery
06/15/2000WO2000033885A1 Supramolecular complexes containing therapeutic agents
06/15/2000WO2000033884A1 Conjugates of lipids and antimicrobial or antineoplastic drugs
06/15/2000WO2000033883A1 Covalent polar lipid conjugates with antimicrobial and antineoplastic drugs for targeting to biological protected sites
06/15/2000WO2000033882A1 A vi-repa conjugate vaccine for immunization against salmonella typhi
06/15/2000WO2000033881A1 Biologically active conjugates having a detectable reporter moiety and method of identification of said derivative
06/15/2000WO2000033880A2 Conjugate used for enriching in neuronal cells
06/15/2000WO2000033879A1 Method for the treatment of inflammation
06/15/2000WO2000033878A2 Stabilization of macrolides
06/15/2000WO2000033877A1 Anhydrous topical skin preparations
06/15/2000WO2000033874A2 Boron neutron capture therapy using pre-targeting methods
06/15/2000WO2000033870A2 New cancer treatments
06/15/2000WO2000033869A2 Use of human prostrate cell lines in cancer treatment
06/15/2000WO2000033866A1 Pharmaceutical compositions containing insulin
06/15/2000WO2000033862A1 Self-emulsifying compositions for drugs poorly soluble in water
06/15/2000WO2000033847A1 Micronized eplerenone compositions
06/15/2000WO2000033835A1 Controlled-release dosage forms comprising zolpidem or a salt thereof
06/15/2000WO2000033825A2 Compositions and methods for amelioration of human female sexual dysfunction
06/15/2000WO2000033822A1 Active ingredient matrix in the form of a biologically resorbable porous non-woven made of collagen fibrils, method for the production and use thereof
06/15/2000WO2000033821A1 Enteric coated pravastatin bead formulation
06/15/2000WO2000033820A2 Nanoparticulate core-shell systems and use thereof in pharmaceutical and cosmetic preparations
06/15/2000WO2000033818A1 Sustained release tablet containing hydrocolloid and cellulose ether
06/15/2000WO2000033817A1 Phospholipid compositions
06/15/2000WO2000033815A1 Fungicide-containing powdery aerosol preparations
06/15/2000WO2000033814A2 Method for administering agents to the central nervous system
06/15/2000WO2000033813A1 Administration of neurotrophic agents to the central nervous system
06/15/2000WO2000033811A2 Improvements in or relating to powders
06/15/2000WO2000033810A1 Use of vitamin b12 in a nasal composition for delivering active agents to the central nervous system
06/15/2000WO2000033809A1 Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period
06/15/2000WO2000033764A1 Biocompatible crosslinked polymers
06/15/2000WO2000033636A1 Stabilization of ground plant seeds
06/15/2000WO2000013672A9 New solid dose form of nanoparticulate naproxen
06/15/2000WO2000010598A3 Recombinant botulinium toxin for the treatment of mucus hypersecretion
06/15/2000WO2000010536A8 Extended release buccal bioadhesive tablet
06/15/2000WO2000010530A8 Oral liquid mucoadhesive compositions
06/15/2000WO2000006244A3 Loading metal particles into cell membrane vesicles and metal particle use for imaging and therapy
06/15/2000WO1999066951A3 Use of bi-specific antibodies for pre-targeting diagnosis and therapy
06/15/2000WO1998051278A3 High efficiency encapsulation of charged therapeutic agents in lipid vesicles
06/15/2000DE19906977C1 Transdermal patch for administering deoxypeganin, useful for treating dementia-associated cognitive impairment and preventing intoxication by organic thiophosphate esters
06/15/2000DE19857425A1 Liquid skin care product, useful e.g. for improving appearance of skin or delivering pharmaceuticals, separates quickly and sharply into oil and aqueous phases after shaking
06/15/2000DE19857151A1 Powdered, water-soluble chlorhexidine salt, useful e.g. as disinfectant in cosmetics, contains anion from specific sugar acids or their lactones
06/15/2000DE19856668A1 Wirkstoffmatrix in Form eines biologisch resorbierbaren porösen Vlieses, Verfahren zu ihrer Herstellung und Verwendung Active substance matrix in the form of a biologically resorbable porous nonwoven, methods for their preparation and use